APA (7th ed.) Citation

Chen, S., Yu, Q., & Zhou, S. (2021). Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Chen, Shubin, Qitao Yu, and Shaozhang Zhou. Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy. Frontiers Media S.A, 2021.

MLA (8th ed.) Citation

Chen, Shubin, et al. Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy. Frontiers Media S.A, 2021.